SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
10-Oct-24 5:07 PM View: | Trevena, Inc. (TRVN) | 08-Oct-24 | Payment of Exercise | 1,822 | $1.47 | $2,678.34 | (7%) 25.72K to 23.89K | |
15-Dec-23 6:57 PM View: | Trevena, Inc. (TRVN) | 14-Dec-23 | Grant | 470,000 | $0.61 | $286,700.00 | 261% 180.05K to 650.05K | 0% |
15-Dec-23 6:57 PM View: | Trevena, Inc. (TRVN) | 14-Dec-23 | Payment of Exercise | 7,123 | $0.61 | $4,345.03 | (1%) 650.05K to 642.92K | 0% |
05-Dec-23 5:51 PM View: | Trevena, Inc. (TRVN) | 02-Dec-23 | Payment of Exercise | 12,028 | $0.59 | $7,096.52 | (6%) 192.07K to 180.05K | (3%) |
06-Jan-23 5:52 PM View: | Trevena, Inc. (TRVN) | 06-Jan-23 | Grant | 100,000 | -- | -- | 109% 92.07K to 192.07K | |
20-Dec-22 4:33 PM View: | Trevena, Inc. (TRVN) | 17-Dec-22 | Payment of Exercise | 1,342 | $1.55 | $2,080.10 | (1%) 93.42K to 92.07K | |
06-Dec-22 4:32 PM View: | Trevena, Inc. (TRVN) | 02-Dec-22 | Payment of Exercise | 3,560 | $3.42 | $12,175.20 | (4%) 96.98K to 93.42K | |
03-Aug-22 9:47 PM View: | Nabriva Therapeutics Plc (NBRV) | 01-Aug-22 | Sale | 8,540 | $0.17 | $1,486.81 | (46%) 18.47K to 9.93K | |
24-Jun-22 6:28 PM View: | Carisma Therapeutics Inc. (CARM) | 22-Jun-22 | Grant | 40,000 | -- | -- | 100% 0 to 40.0K | |
21-Dec-21 4:17 PM View: | Trevena, Inc. (TRVN) | 17-Dec-21 | Payment of Exercise | 33,546 | $0.70 | $23,482.20 | (1%) 2.46M to 2.42M | 1% |
08-Dec-21 4:16 PM View: | Trevena, Inc. (TRVN) | 06-Dec-21 | Payment of Exercise | 93,561 | $0.65 | $60,814.60 | (4%) 2.55M to 2.46M | (4%) |
03-Dec-21 4:59 PM View: | Trevena, Inc. (TRVN) | 02-Dec-21 | Grant | 1,250,000 | -- | -- | 96% 1.3M to 2.55M | |
04-Aug-21 9:04 PM View: | Nabriva Therapeutics Plc (NBRV) | 02-Aug-21 | Market Sale | 777 | $1.20 | $932.40 | (4%) 19.25K to 18.47K | (2%) |
30-Jul-21 8:20 PM View: | Nabriva Therapeutics Plc (NBRV) | 28-Jul-21 | Grant | 17,500 | -- | -- | 1000% 1.75K to 19.25K | |
28-Jun-21 5:33 PM View: | Trevena, Inc. (TRVN) | 28-Jun-21 | Market Purchase | 56,200 | $1.79 | $100,542.00 | 5% 1.25M to 1.3M | (58%) |
18-Dec-20 7:45 PM View: | Trevena, Inc. (TRVN) | 17-Dec-20 | Grant | 471,100 | -- | -- | 59% 792.96K to 1.26M | |
09-Dec-20 4:37 PM View: | Trevena, Inc. (TRVN) | 07-Dec-20 | Payment of Exercise | 132,934 | $2.27 | $301,760.00 | (14%) 925.89K to 792.96K | 67% |
31-Jul-20 4:56 PM View: | Nabriva Therapeutics Plc (NBRV) | 29-Jul-20 | Grant | 17,500 | -- | -- | 100% 0 to 17.5K | |
13-Dec-19 5:38 PM View: | Trevena, Inc. (TRVN) | 12-Dec-19 | Grant | 657,000 | -- | -- | 244% 268.89K to 925.89K | |
04-Dec-19 5:46 PM View: | Trevena, Inc. (TRVN) | 02-Dec-19 | Payment of Exercise | 17,804 | $0.69 | $12,265.20 | (6%) 286.7K to 268.89K | (8%) |
04-Jun-19 4:49 PM View: | Trevena, Inc. (TRVN) | 03-Jun-19 | Payment of Exercise | 17,802 | $1.17 | $20,828.30 | (6%) 304.5K to 286.7K | 36% |
05-Feb-19 8:41 AM View: | Trevena, Inc. (TRVN) | 01-Feb-19 | Grant | 50,000 | $1.02 | $51,000.00 | 20% 254.5K to 304.5K | (26%) |
07-Dec-18 4:39 PM View: | Trevena, Inc. (TRVN) | 06-Dec-18 | Grant | 250,000 | -- | -- | 5556% 4.5K to 254.5K | |
10-Nov-16 6:12 PM View: | Trevena, Inc. (TRVN) | 09-Nov-16 | Market Purchase | 4,000 | $4.34 | $17,360.00 | 800% 0.5K to 4.5K | (84%) |